Brooktree Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Hold
2,850
0.17% 42
2026
Q1
$243K Hold
2,850
0.19% 43
2025
Q4
$225K Hold
2,850
0.15% 39
2025
Q3
$228K Hold
2,850
0.14% 42
2025
Q2
$259K Buy
+2,850
New +$260K 0.17% 37

Other funds holding CL

Brooktree Capital Management's CL Position: Q2 2026 in Review

Brooktree Capital Management held its Colgate-Palmolive (CL) position steady in Q2 2026 at 2,850 shares worth $261K. The position accounts for 0.17% of the portfolio, ranked #42.

Brooktree Capital Management first reported a position in CL in Q2 2025 and has held it in 5 quarters since. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Brooktree Capital Management held 2,850 shares of Colgate-Palmolive worth $261K as of Q2 2026.
  • Brooktree Capital Management left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.17% of Brooktree Capital Management's portfolio in Q2 2026, its #42 holding.
  • Brooktree Capital Management first reported a position in Colgate-Palmolive in Q2 2025 and has held it in 5 quarters since.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Brooktree Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.